Regeneron Pharmaceuticals (REGN)
P/OCF Ratio
18.75×
TTM · Retrieved:
REGN P/OCF Ratio
Current (TTM)18.75×retrieved
Current (TTM)18.75×retrieved
REGN Quarterly P/OCF Ratio (0.00× → 112.23×)
Latest values, visible window
High-resolution chart · PNG
REGN p/ocf ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | P/OCF Ratio |
|---|---|
| 112.2263× | |
| 74.4782× | |
| 67.8444× | |
| 35.9932× | |
| 48.2152× | |
| 64.752× | |
| 60.8651× | |
| 88.0104× | |
| 322.7793× | |
| 69.0854× | |
| 85.9188× | |
| 78.5073× | |
| 75.1993× | |
| 64.3469× | |
| 44.886× | |
| 123.5563× | |
| 119.399× | |
| 37.5732× | |
| 28.2687× | |
| 18.8277× | |
| 93.5802× | |
| 78.2079× | |
| 41.3646× | |
| -232.2328× | |
| 72.4529× | |
| 80.4683× | |
| 54.5052× | |
| 56.8439× | |
| 192.6595× | |
| 52.7991× | |
| 58.8033× | |
| 100.1278× | |
| 100.0159× | |
| 63.9414× | |
| 76.8423× | |
| 126.0666× | |
| -1,865.1273× | |
| 125.329× | |
| 112.4821× | |
| 71.9195× | |
| 101.4958× | |
| 914.8827× | |
| 222.4776× | |
| 60.3605× | |
| 227.8756× | |
| -508.2529× | |
| 236.5052× | |
| 249.2467× | |
| 94.9079× | |
| 628.1685× | |
| 111.9303× | |
| 382.3035× | |
| 198.6054× | |
| 226.3642× | |
| 202.7072× | |
| -7,230.5473× | |
| -137.846× | |
| -125.2016× | |
| -101.1228× | |
| -113.3813× | |
| -150.6204× | |
| -378.7278× | |
| -68.8147× | |
| 13.9223× | |
| -144.0714× | |
| -214.9952× | |
| -41.7585× | |
| -156.9348× | |
| -245.805× | |
| -108.0343× | |
| -40.5672× | |
| -41.4768× | |
| 183.3579× | |
| -84.1639× | |
| 37.3026× | |
| -114.0462× | |
| -336.99× | |
| -153.4393× | |
| 24.6862× | |
| -60.313× | |
| -35.2914× | |
| 178.7363× | |
| -44.9361× | |
| -35.4201× | |
| -16.4134× | |
| 8.6084× | |
| -41.9331× | |
| -134.2616× | |
| 33.4049× | |
| -40.4016× | |
| -28.4573× | |
| 15.0635× | |
| -19.1898× | |
| 279.1125× | |
| -26.3176× | |
| -24.8732× | |
| -20.668× | |
| -42.7358× | |
| -69.6307× | |
| -44.9691× |